{"news_desk": "National", "print_page": "1", "section_name": "Science", "subsection_name": null, "byline": {"original": "By SABRINA TAVERNISE and ANDREW POLLACK", "person": [{"rank": 1, "role": "reported", "firstname": "Sabrina", "organization": "", "lastname": "TAVERNISE"}, {"rank": 2, "role": "reported", "firstname": "Andrew", "organization": "", "lastname": "POLLACK"}]}, "abstract": "Panel's surprise recommendation to FDA to approve Sprout Pharmaceutical drug flibanserin, first pill to bolster women's libido, raises questions about coalition of prominent feminists who campaigned for drug's approval; campaign divided women's health community, with critics saying it politicized scientific process and potentially played down health risks; those paid to promote drug include Susan Scanlan, whose Even the Score group argued that women's sexuality has been marginalized by medical establishment.", "type_of_material": "News", "word_count": "1769", "lead_paragraph": "While some feminists lend heft to a campaign for a pill to bolster women&#8217;s libido, other groups opted not to join the campaign, concerned that calls of gender bias would undermine what should be an impartial scientific process.", "pub_date": "2015-06-14T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Aid to Women, or Bottom Line? Advocates Split on Libido Pill ", "print_headline": "Aid to Women, or Bottom Line? Advocates Split on Libido Pill"}, "snippet": "While some feminists lend heft to a campaign for a pill to bolster women&#8217;s libido, other groups opted not to join the campaign, concerned that calls of gender bias would undermine what should be an impartial scientific process.", "multimedia": [{"height": 126, "url": "images/2015/06/14/us/14libido-JP-SUB/14libido-JP-SUB-thumbWide.jpg", "legacy": {"widewidth": "190", "wideheight": "126", "wide": "images/2015/06/14/us/14libido-JP-SUB/14libido-JP-SUB-thumbWide.jpg"}, "type": "image", "width": 190, "subtype": "wide"}, {"height": 400, "url": "images/2015/06/14/us/14libido-JP-SUB/14libido-JP-SUB-articleLarge.jpg", "legacy": {"xlargewidth": "600", "xlargeheight": "400", "xlarge": "images/2015/06/14/us/14libido-JP-SUB/14libido-JP-SUB-articleLarge.jpg"}, "type": "image", "width": 600, "subtype": "xlarge"}, {"height": 75, "url": "images/2015/06/14/us/14libido-JP-SUB/14libido-JP-SUB-thumbStandard.jpg", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2015/06/14/us/14libido-JP-SUB/14libido-JP-SUB-thumbStandard.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "subtype": "thumbnail"}], "web_url": "http://www.nytimes.com/2015/06/14/us/aid-to-women-or-bottom-line-advocates-split-on-libido-pill.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Women and Girls", "name": "subject"}, {"rank": "2", "is_major": "Y", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "3", "is_major": "Y", "value": "Sex", "name": "subject"}, {"rank": "4", "is_major": "Y", "value": "Sprout Pharmaceuticals Inc", "name": "organizations"}, {"rank": "7", "is_major": "Y", "value": "Food and Drug Administration", "name": "organizations"}, {"rank": "8", "is_major": "N", "value": "Clinical Trials", "name": "subject"}, {"rank": "9", "is_major": "N", "value": "National Women's Health Network", "name": "organizations"}], "blog": [], "_id": "557c94c738f0d85fbd03bfd7", "source": "The New York Times"}